Risk of Stroke, Death, and Myocardial Infarction Following Transcarotid Artery Revascularization vs Carotid Endarterectomy in Patients With Standard Surgical Risk.

Importance Carotid artery stenting has been limited to use in patients with high surgical risk; outcomes in patients with standard surgical risk are not well known. Objective To compare stroke, death, and myocardial infarction outcomes following transcarotid artery revascularization vs carotid endarterectomy in patients with standard surgical risk. Design, Setting, and Participants This retrospective propensity-matched cohort study was conducted from August 2016 to August 2019 with follow-up until August 31, 2020, using data from the multicenter Vascular Quality Initiative Carotid Artery Stent and Carotid Endarterectomy registries. Patients with standard surgical risk, defined as those lacking Medicare-defined high medical or surgical risk characteristics and undergoing transcarotid artery revascularization (n = 2962) or carotid endarterectomy (n = 35 063) for atherosclerotic carotid disease. In total, 760 patients were excluded for treatment of multiple lesions or in conjunction with other procedures. Exposures Transcarotid artery revascularization vs carotid endarterectomy. Main Outcomes and Measures The primary outcome was a composite end point of 30-day stroke, death, or myocardial infarction or 1-year ipsilateral stroke. Results After 1:3 matching, 2962 patients undergoing transcarotid artery revascularization (mean [SD] age, 70.4 [6.9] years; 1910 [64.5%] male) and 8886 undergoing endarterectomy (mean [SD] age, 70.0 [6.5] years; 5777 [65.0%] male) were identified. There was no statistically significant difference in the risk of the primary composite end point between the 2 cohorts (transcarotid 3.0% vs endarterectomy 2.6%; absolute difference, 0.40% [95% CI, -0.43% to 1.24%]; relative risk [RR], 1.14 [95% CI, 0.87 to 1.50]; P = .34). Transcarotid artery revascularization was associated with a higher risk of 1-year ipsilateral stroke (1.6% vs 1.1%; absolute difference, 0.52% [95% CI, 0.03 to 1.08]; RR, 1.49 [95% CI, 1.05 to 2.11%]; P = .02) but no difference in 1-year all-cause mortality (2.6% vs 2.5%; absolute difference, -0.13% [95% CI, -0.18% to 0.33%]; RR, 1.04 [95% CI, 0.78 to 1.39]; P = .67). Conclusions and Relevance In this study, the risk of 30-day stroke, death, or myocardial infarction or 1-year ipsilateral stroke was similar in patients undergoing transcarotid artery revascularization compared with those undergoing endarterectomy for carotid stenosis.

[1]  P. Goodney,et al.  The Impact Of Carotid Lesion Calcification On Outcomes Of Carotid Artery Stenting. , 2021, Journal of vascular surgery.

[2]  V. Kashyap,et al.  TransCarotid Revascularization With Dynamic Flow Reversal Versus Carotid Endarterectomy in the Vascular Quality Initiative Surveillance Project , 2020, Annals of surgery.

[3]  G. LaMuraglia,et al.  Early Outcomes in the ROADSTER 2 Study of Transcarotid Artery Revascularization in Patients With Significant Carotid Artery Disease , 2020, Stroke.

[4]  V. Kashyap,et al.  Association of Transcarotid Artery Revascularization vs Transfemoral Carotid Artery Stenting With Stroke or Death Among Patients With Carotid Artery Stenosis. , 2019, JAMA.

[5]  M. Schermerhorn,et al.  Association between Medicare high‐risk criteria and outcomes after carotid revascularization procedures , 2018, Journal of vascular surgery.

[6]  C. Moy,et al.  Carotid revascularization and medical management for asymptomatic carotid stenosis: Protocol of the CREST-2 clinical trials , 2017, International journal of stroke : official journal of the International Stroke Society.

[7]  S. Macdonald,et al.  Results of the ROADSTER multicenter trial of transcarotid stenting with dynamic flow reversal. , 2015, Journal of vascular surgery.

[8]  Marije Bosch,et al.  Systematic Review of Guidelines for the Management of Asymptomatic and Symptomatic Carotid Stenosis , 2015, Stroke.

[9]  Rodney A. White,et al.  The impact of Centers for Medicare and Medicaid Services high-risk criteria on outcome after carotid endarterectomy and carotid artery stenting in the SVS Vascular Registry. , 2013, Journal of vascular surgery.

[10]  J. Spertus,et al.  Outcomes of Carotid Endarterectomy in the Elderly: Report From the National Cardiovascular Data Registry , 2013, Stroke.

[11]  J. Freischlag,et al.  The impact of race and ethnicity on the outcome of carotid interventions in the United States. , 2012, The Journal of surgical research.

[12]  T. Brott,et al.  Age and Outcomes After Carotid Stenting and Endarterectomy: The Carotid Revascularization Endarterectomy Versus Stenting Trial , 2011, Stroke.

[13]  Michael D Hill,et al.  Stenting versus endarterectomy for treatment of carotid-artery stenosis. , 2010, The New England journal of medicine.

[14]  P. Dorman,et al.  Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial , 2010, The Lancet.

[15]  E. Halm,et al.  Racial and Ethnic Disparities in Outcomes and Appropriateness of Carotid Endarterectomy: Impact of Patient and Provider Factors , 2009, Stroke.

[16]  P. Iranpour,et al.  Carotid endarterectomy as the criterion standard in high-risk elderly patients. , 2008, Archives of surgery.

[17]  Xavier Ducrocq,et al.  Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. , 2006, The New England journal of medicine.

[18]  J. Semmens,et al.  Long-Term Relative Survival in Elderly Patients After Carotid Endarterectomy: A Population-Based Study , 2003, Stroke.